The manifestations of pheochromocytoma crisis

Written by Chen Yu Fei
Neurosurgery
Updated on September 11, 2024
00:00
00:00

For patients with pheochromocytoma, during a crisis, it generally manifests as a sudden increase in the patient's blood pressure, which can rise to above 200-300 mmHg. Additionally, the patient experiences severe headaches and dizziness, severe nausea and vomiting. Some patients may experience significant discomfort and tachycardia, arrhythmias. Some patients also suffer from abdominal or chest pain, labored breathing, and difficulty breathing, and even blurred vision. In severe cases, the excessively high blood pressure can lead to hypertensive cerebral hemorrhage or other unexpected cardiovascular and cerebrovascular diseases. The patient’s vital signs are extremely unstable, often accompanied by multiple organ dysfunction or failure.

Other Voices

doctor image
home-news-image
Written by Chen Yu Fei
Neurosurgery
51sec home-news-image

The manifestations of pheochromocytoma crisis

For patients with pheochromocytoma, during a crisis, it generally manifests as a sudden increase in the patient's blood pressure, which can rise to above 200-300 mmHg. Additionally, the patient experiences severe headaches and dizziness, severe nausea and vomiting. Some patients may experience significant discomfort and tachycardia, arrhythmias. Some patients also suffer from abdominal or chest pain, labored breathing, and difficulty breathing, and even blurred vision. In severe cases, the excessively high blood pressure can lead to hypertensive cerebral hemorrhage or other unexpected cardiovascular and cerebrovascular diseases. The patient’s vital signs are extremely unstable, often accompanied by multiple organ dysfunction or failure.

doctor image
home-news-image
Written by Chen Yu Fei
Neurosurgery
47sec home-news-image

Which department should I go to for pheochromocytoma?

When pheochromocytoma occurs, it is generally recommended to visit the endocrinology department of a local hospital. Pheochromocytoma refers to tumors originating from the neuroectoderm, specifically chromaffin tissue. These tumors usually secrete catecholamines and can be classified into various types based on their origin. Patients typically exhibit a pronounced hypermetabolic state, such as malignant hypertension or hyperglycemia, and some suffer significant damage to the heart, kidneys, liver, and brain tissue due to malignant hypertension. For instance, this can lead to heart failure or hypertensive cerebral hemorrhage, severely threatening the patient's life. Treatment typically involves surgical intervention.

doctor image
home-news-image
Written by Chen Yu Fei
Neurosurgery
45sec home-news-image

Pheochromocytoma clinical manifestations

Pheochromocytoma typically presents with severe hypertension, with blood pressure even reaching above 200/140 mmHg, accompanied by significant discomfort, such as profuse sweating, chest pain, obvious difficulty in breathing, chest tightness, shortness of breath, and other clinical manifestations. Moreover, if not treated timely and effectively, it can even lead to a hypertensive crisis. It also poses a severe threat to the patient’s heart, kidneys, liver, and brain tissues. Some patients might develop cerebrovascular diseases due to very high blood pressure, such as hypertensive cerebral hemorrhage, which can threaten the patient's life.

doctor image
home-news-image
Written by Gan Jun
Endocrinology
49sec home-news-image

Can malignant pheochromocytoma be cured?

When pheochromocytoma becomes malignant, it can be cured through clinical approaches, although malignant pheochromocytoma mainly refers to those that have distant metastases. It primarily exhibits aggressive growth or is accompanied by metastases to other organs, and surgery cannot completely remove it, leading to a high recurrence rate post-surgery. Generally, the five-year survival rate for patients with malignant pheochromocytoma does not exceed half. If treated with chemotherapy or arterial embolization, it can control the patient's blood pressure and alleviate the tumor burden, thereby extending the survival period. In summary, the treatment of malignant pheochromocytoma is relatively challenging, has a high recurrence rate, and poses a significant threat to human life.

doctor image
home-news-image
Written by Hao Li Bin
Neurosurgery
59sec home-news-image

Can pheochromocytoma metastasize?

Pheochromocytoma is a special type of tumor originating from chromaffin cells of the adrenal gland. Most of these tumors are benign, with only a minority of patients experiencing malignancy. Clinically, the likelihood of tumor malignancy is about 10%. Most patients have a good prognosis after surgical removal, and if the tumor shows distant metastasis, it can be determined that the disease has become malignant. Due to the unique origin of pheochromocytomas in the adrenal medulla chromaffin cells, the tumor tissue continuously grows in the body and synthesizes and metabolizes catecholamines such as adrenaline, dopamine, and noradrenaline. Clinically, nearly 90% of patients do not develop cancer throughout their lives, therefore most pheochromocytomas are benign. However, about 10% of patients experience distant metastases, and once metastasized, it is considered a malignant tumor.